worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Novartis Investor Relations

Novartis Investor Relations

Annual results

2007

Annual Results 2007 - Jan 17, 2008

2007
(USD m)
2006
(USD m)
% change
(USD)
Net sales
39,800
37,020
8 (lc: 3)
Operating income and divestment gains
% of net sales
12,933


32.5%
8,174


22.1%
58
Net income
% of net sales
11,968
30.1%
7,202
19.5%
66
Basic earnings per share
USD 5.15
USD 3.06
68

Operating income includes charge for Corporate environmental provision increase of USD 590 million in the 2007 third quarter and a USD 444 million restructuring charge in the 2007 fourth quarter for the “Forward” initiative as well as pre-tax divestment gains of USD 5.8 billion from Medical Nutrition and Gerber.

 

Media release


The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.

 

SIX

NYSE

 
 
 
 

Corporate publications

You may download or order our latest Annual Report or other publications from our Corporate Publications section.

2010 key events

Jan 26 - Fourth quarter and full-year 2009 results

Feb 26 - Annual General Meeting

Apr 20 - First quarter 2010 results

Jul 15 - Second quarter and first half 2010 results

Oct 21 - Third quarter and first nine months 2010 results